GE-2270A for COVID-19

 GE-2270A has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed GE-2270A in detail.
Pham et al., A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing, Nature Machine Intelligence, doi:10.1038/s42256-020-00285-9